TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,428 | -84.6% | 11,780 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $22,264 | +26.8% | 11,780 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $17,552 | -7.6% | 11,780 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $19,000 | -20.8% | 11,780 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $24,000 | -22.6% | 11,780 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $31,000 | -6.1% | 11,780 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -25.0% | 11,780 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | -42.1% | 11,780 | 0.0% | 0.01% | -45.5% |
| Q2 2021 | $76,000 | -20.8% | 11,780 | 0.0% | 0.01% | -31.2% |
| Q1 2021 | $96,000 | -48.7% | 11,780 | -26.4% | 0.02% | -59.0% |
| Q4 2020 | $187,000 | +125.3% | 16,000 | 0.0% | 0.04% | +95.0% |
| Q3 2020 | $83,000 | – | 16,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |